ArticleAdvanced healthcare materials2026
A Personalized, 3D Printed Polymeric Device for the Prevention of Post-Myocardial Infarction Cardiac Remodeling.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Myocardial remodeling and dilatation following myocardial infarction initiates a life-threatening process leading to heart failure. As every patient's anatomy and pathophysiology are unique, developing a custom-made cardiac restraint device tailored for each patient is crucial. This study introduces a personalized, 3D printed cardiac restraint device (CARD) aimed at restoring cardiac physiology and preventing cardiac remodeling after myocardial infarction. Personalization is achieved by 3D printing the CARD based on precise anatomical and physiological data from the CT and Echocardiography scan. The rationally designed printable molecules ("inks") key to this research are developed using a modular synthetic strategy. The inks consist of a triblock structure consisting of a central polypropylene oxide (PPO) segment and two side polycaprolactone (PCL) blocks, end-capped with the C═C double bonds required for printing. Studies conducted on rat and swine myocardial infarction models demonstrated the capability of the integrated use of imaging, designing and 3D printing, to fabricate a CARD that accommodates to the cardiac anatomy without compromising the diastolic function. Improved hemodynamic profiles following CARD implantation suggest enhanced left ventricular function and better fluid dynamics within both cardiac and pulmonary systems. No device-related mortality occurred, and the CARD remained securely in place for 28 days post-implantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.